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tress Testing After
oronary Revascularization
oo Much, Too Soon*
eorge A. Beller, MD
harlottesville, Virginia
n response to the observation that the number of stress
maging procedures was rising annually at a very high rate,
he American College of Cardiology Foundation proposed a
ethod for evaluating the appropriateness of cardiovascular
maging using technical panels of experts who evaluated
ossible clinical scenarios where imaging would be used (1).
he panels developed appropriate use criteria (AUC) for
hese varied clinical indications using a modified Delphi
xercise. They combined evidence-based medical informa-
ion and expert opinion. For example, the revised AUC for
adionuclide imaging (2) lists 67 clinical scenarios scored by
he panels on a scale of 1 to 9. Indications for radionuclide
maging deemed appropriate were those with scores ranging
rom 7 to 9; uncertain indications were those that yielded a
edian score of 4 to 6; and inappropriate indications have
edian scores from 1 to 3. The inappropriate indications
all into several categories, including testing of asymptom-
tic or low-risk patients, routine testing early after coronary
evascularization, pre-operative testing of low-risk patients
ith good functional capacity before noncardiac surgery,
nd detection of coronary artery disease (CAD) in stable
ymptomatic patients who have a low pre-test probability of
AD, have an interpretable baseline electrocardiogram, and
re able to exercise (2).
See page 1328
Several groups have sought to determine how well aca-
emic and community physicians fared with respect to
dherence to the AUC for stress radionuclide imaging and
tress echocardiography (3–6). The rate of inappropriate
ndications in these studies ranges from 13% to 14%. A
ecent multicenter study (6) comprising 6 diverse clinical
ites and 6,351 prospectively enrolled patients who under-
ent stress single-photon emission computed tomography
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.t
From the Cardiovascular Division, University of Virginia Health System, Char-
ottesville, Virginia. Dr. Beller reports that he has no relationships to disclose.yocardial perfusion imaging (MPI) found that 14% of
ndications were inappropriate, 15% were uncertain, and
1% were appropriate. As observed in the single-center
tudies, the most frequent inappropriate indications for
tress single-photon emission computed tomography MPI
as for detecting CAD in asymptomatic patients at low
isk, followed by testing asymptomatic patients after revas-
ularization 2 years after percutaneous coronary interven-
ion (PCI) who had symptoms before PCI. More inappro-
riate studies were ordered by noncardiologists than
ardiologists and more in women than in men. By multi-
ariate analysis, asymptomatic status was the best predictor
f an inappropriate classification.
In the present issue of the Journal, Shah et al. (7)
etrospectively examined the use and timing of stress testing
ore than 90 days after coronary revascularization in
atients age 18 to 64 years from a national health insurance
laims database. They also looked at subsequent rates of
oronary angiography and repeat revascularization after
tress testing. They found that among 28,177 patients
ndergoing revascularization, 59% had at least 1 cardiac
tress test within 24 months (61% of PCI and 51% of
oronary artery bypass graft [CABG] patients). Nuclear
maging was the predominant testing method. Of interest
as the observation that the major spikes for stress testing
rdering were at 6 and 12 months after revascularization,
resumably coinciding with outpatient follow-up visits.
lthough more than one-half of the patients underwent
tress testing, only 11% had subsequent cardiac catheteriza-
ion within 30 days of testing and only 5% of all patients
ho underwent stress testing had repeat revascularization.
here was also marked regional variation in the rate of stress
esting after revascularization, with up to a 50% difference in
ates of testing between regions. This regional variation is
ypical for cardiac diagnostic and therapeutic procedures
erformed in the U.S. (8,9). The study by Shah et al. (7)
uggests excessive and inappropriate use of stress testing,
ostly with imaging, after coronary revascularization. That
s too much imaging too soon after revascularization. From
linical experience and published studies of outcomes
fter PCI and CABG, it is doubtful that 60% of PCI
atients and 50% of CABG patients had significant
schemic symptoms that warranted stress imaging. Shah
t al. (7) cite data from the National Heart, Lung, and
lood Institute’s Dynamic registry indicating that 18% of
CI patients report angina symptoms at the 1-year
ollow-up, a figure considerably lower than the 60% rate
f stress testing after PCI reported in their study. With
ore drug-eluting stents being used for PCI and greater
xperience of operators in the interventional laboratory,
he percentage of patients with recurrent angina at 1 year
fter PCI has dropped considerably.
The data from Shah et al. (7) support prior reports of
nappropriate routine imaging tests in asymptomatic pa-
ients after uncomplicated PCI or CABG. A major limita-
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Stress Testing After Coronary Revascularization October 12, 2010:1335–7ion of the study, noted by the authors, is the lack of
nformation on the percentage of patients who had symp-
oms after revascularization for which a stress test would be
ppropriate. They report only the International Classifica-
ion of Diseases-Ninth Edition codes for the common
iagnoses at the time of testing, and although some of these
odes provide potential symptom states, the most common
i.e., 414) reflects only known disease (CAD). Billing data
or clinical syndromes may be inaccurate. Nevertheless, the
act that approximately only 10% of the patients who
nderwent testing had downstream cardiac catheterization
mplies that most of the stress tests studies were low risk and
ikely were not indicated in the first place. Because the
nvestigators eliminated any tests performed before 90 days
fter revascularization, those stress tests performed for
ardiac rehabilitation were probably not included in their
ata after 90 days.
The claims data reviewed by Shah et al. (7) spanned the
eriod from July 2004 through June 2007. The AUC for use
f stress imaging procedures were perhaps not yet fully
ppreciated in that time. Physicians today are more cogni-
ant of AUC, as are health insurance companies pre-
uthorizing stress tests. The latest AUC for stress radionu-
lide imaging (2) indicate that it is appropriate to perform a
tress MPI to evaluate symptomatic patients after revascu-
arization with an ischemic equivalent of 5 years or more
fter CABG. It clearly states that it is inappropriate to
erform stress imaging for risk assessment after revascular-
zation 2 years after PCI in asymptomatic patients.
nterestingly, the indication for stress MPI 2 years after
CI in an asymptomatic patient received an uncertain
ndication. This would not apply to the study by Shah et al.
7), because they report stress test use rates only within 24
onths after PCI, a period when the AUC clearly state such
esting is inappropriate in asymptomatic patients.
There is one caveat regarding the value of post-revas-
ularization stress imaging that deserves mention. In the
OURAGE (Clinical Outcomes Utilizing Revasculariza-
ion and Aggressive Drug Evaluation) trial nuclear sub-
tudy, Shaw et al. (10) found that patients in either the
ptimal medical therapy arm or the optimal medical therapy
lus PCI arm who did not have at least a 5% reduction in
schemia 6 to 18 months after assigned treatment had a
orse cumulative event-free survival at follow-up compared
ith those who had a significant reduction in myocardial
schemia. Similarly, regardless of treatment assignment, the
agnitude of residual ischemia at follow-up was propor-
ional to the risk of death or nonfatal infarction. The
revalence and extent of residual ischemia were determined
y serial imaging before and 6 to 18 months after PCI or
fter randomization to medical therapy without a PCI. Only
1% of the PCI patients who underwent serial imaging had
ngina at the time of the follow-up stress test. The number
f patients in this substudy was too small to make definitive
onclusions and was considered to be hypothesis generating.
f, in the future, a larger randomized study comparing aerial imaging strategy versus no post-procedure imaging in
symptomatic patients who have undergone PCI shows a
enefit of detecting silent residual ischemia that is associ-
ted with better long-term outcomes, the appropriateness of
tress testing after PCI will have to be re-evaluated. This
ssumes that eliminating or reducing residual ischemia
dentified in such patients can be accomplished and that it
ill be associated with improved infarct-free survival. Out-
omes will have to be substantially better than with just
ffective control of risk factors such as reducing low-density
ipoprotein cholesterol levels, maintaining blood pressure in
he normotensive range, weight reduction, exercise therapy,
nd smoking cessation, but without routine post-treatment
erial single-photon emission computed tomography MPI.
In summary, nearly 25% of all inappropriate stress imag-
ng studies are performed in asymptomatic patients who
ave undergone revascularization 2 years after PCI (6).
he study by Shah et al. (7), despite its limitations as a
etrospective analysis of insurance claims, highlights the
igh and probably excessive use of stress testing in the first
ear after revascularization, with marked regional variation
n test use. This study serves as another wake-up call to
ardiovascular specialists to be more diligent in adhering to
vidence-based practice guidelines and AUC. The value of
tress imaging is greatest in the evaluation of risk for future
ardiac events in symptomatic patients to identify those who
ould benefit the most from revascularization strategies.
ur goal as cardiovascular specialists is to educate patients
nd referral physicians regarding the appropriate indications
or expensive stress imaging procedures and where diagnos-
ic and prognostic value is greatest. If we fail in this duty, we
ill be coerced into constantly securing pre-authorization
rom payers for diagnostic imaging tests to be performed for
ur patients. The problems with pre-authorization for
ormal approval of use of testing have been well described
11). They include no evidence for improved quality of care,
he favoring of indiscriminate volume reduction, the lack of
ransparency, the fact that such measures are not based on
UC, inconsistent processes often characterized by confu-
ion and inefficiency, reduced timeliness, an unstated goal of
teerage to the test of least resistance, labor intensiveness,
nd scant data available for feedback or education (11).
hus, it behooves cardiovascular specialists to advocate for
nd adhere to accepted AUC developed by our own scien-
ific societies.
eprint requests and correspondence: Dr. George A. Beller,
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ox 800158, Charlottesville, Virginia 22908-0158. E-mail: gbeller@
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